# AB-1002 in Patients With Class III Heart Failure

> **NCT04179643** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AskBio Inc** · enrollment: 17 (estimated)

## Conditions studied

- Congestive Heart Failure
- Heart Failure
- Heart Disease, Ischemic
- Cardiovascular Diseases
- Heart Failure, Systolic
- Heart Failure，Congestive
- Heart Arrhythmia
- Heart Failure, Diastolic
- Heart; Complications

## Interventions

- **BIOLOGICAL:** 3 x 10e13vg AB-1002

## Key facts

- **NCT ID:** NCT04179643
- **Lead sponsor:** AskBio Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-20
- **Primary completion:** 2024-08-20
- **Final completion:** 2026-09-30
- **Target enrollment:** 17 (ESTIMATED)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179643, "AB-1002 in Patients With Class III Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04179643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*